Literature DB >> 23337067

COPD exacerbations: causes, prevention, and treatment.

Alex J Mackay1, John R Hurst.   

Abstract

The mechanisms of chronic obstructive pulmonary disease exacerbation are complex. Respiratory viruses (in particular rhinovirus) and bacteria play a major role in the cause of these events. A distinct group of patients seems susceptible to frequent exacerbations, irrespective of disease severity, and this phenotype is stable over time. Many current therapeutic strategies help reduce exacerbation frequency. Further work is required to develop novel anti-inflammatory therapies for exacerbation prevention and treatment. This article focuses on the cause of chronic obstructive pulmonary disease exacerbations, and the current preventative and acute interventions available.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23337067     DOI: 10.1016/j.iac.2012.10.006

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  18 in total

Review 1.  Defining phenotypes in COPD: an aid to personalized healthcare.

Authors:  Andrea Segreti; Emanuele Stirpe; Paola Rogliani; Mario Cazzola
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

Review 2.  Impact of air quality on lung health: myth or reality?

Authors:  Elisa Marino; Massimo Caruso; Davide Campagna; Riccardo Polosa
Journal:  Ther Adv Chronic Dis       Date:  2015-09       Impact factor: 5.091

3.  Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.

Authors:  Nadia Khorasani; Josephine Baker; Malcolm Johnson; Kian Fan Chung; Pankaj K Bhavsar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-02-04

4.  Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice.

Authors:  L C Oostwoud; P Gunasinghe; H J Seow; J M Ye; S Selemidis; S Bozinovski; R Vlahos
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

5.  MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction.

Authors:  Stefen A Boehme; Karin Franz-Bacon; John Ludka; Danielle N DiTirro; Tai Wei Ly; Kevin B Bacon
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

6.  Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists.

Authors:  Vamsi Bollu; Annie Guérin; Geneviève Gauthier; Robert Hiscock; Eric Q Wu
Journal:  Drugs Real World Outcomes       Date:  2017-03

7.  Pseudomonas aeruginosa infection increases the readmission rate of COPD patients.

Authors:  Juwhan Choi; Jee Youn Oh; Young Seok Lee; Gyu Young Hur; Sung Yong Lee; Jae Jeong Shim; Kyung Ho Kang; Kyung Hoon Min
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-02

Review 8.  New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.

Authors:  Kurt Brassington; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Clin Sci (Lond)       Date:  2019-04-12       Impact factor: 6.124

9.  The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Juwhan Choi; Jee Youn Oh; Young Seok Lee; Gyu Young Hur; Sung Yong Lee; Jae Jeong Shim; Kyung Ho Kang; Kyung Hoon Min
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-06

Review 10.  COPD and stroke: are systemic inflammation and oxidative stress the missing links?

Authors:  Victoria Austin; Peter J Crack; Steven Bozinovski; Alyson A Miller; Ross Vlahos
Journal:  Clin Sci (Lond)       Date:  2016-07-01       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.